Efficacy and safety of potent P2Y12 inhibitors vs. clopidogrel in elderly patients with acute coronary syndrome.
10.1097/CM9.0000000000001119
- Author:
Li-Man LUO
1
;
Zhan-Qi PANG
2
;
Meng-Lu FU
1
;
Yuan-Yuan LI
1
;
Ling TU
1
;
Xi-Zhen XU
3
Author Information
1. Department of Geriatric Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
2. Department of Cardiology, Dalian Municipal Central Hospital affiliated of Dalian Medical University, Dalian, Liaoning 116033, China.
3. Division of Cardiology and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
- Publication Type:Journal Article
- MeSH:
Acute Coronary Syndrome/drug therapy*;
Aged;
Clopidogrel/therapeutic use*;
Humans;
Percutaneous Coronary Intervention;
Platelet Aggregation Inhibitors/therapeutic use*;
Purinergic P2Y Receptor Antagonists/therapeutic use*;
Ticagrelor/therapeutic use*;
Treatment Outcome
- From:
Chinese Medical Journal
2020;133(21):2628-2629
- CountryChina
- Language:English
